Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • clovip
    Junior Member
    • Jun 2008
    • 3

    Postdoc "Knowledge models in neurodegenerative diseases" (Paris, France)

    JOB OFFER - Postdoctoral fellow - Knowledge models for analysis and interpretation of genetic data in neurodegenerative diseases

    Keywords: computational biology, bioinformatics, knowledge models, ontologies, genomic data

    LABORATORY: ARAMIS Laboratory, Brain and Spine Institute (ICM), CNRS/Inserm/Université Pierre et Marie Curie/Inria, Hospital Pitié-Salpêtrière, Paris, France


    PROJECT
    Neurodegenerative diseases (such as Alzheimer’s disease and Parkinson’s disease) are major public health concerns. To develop new treatments for these diseases, it is crucial to identify at the earliest stage (ideally presymptomatic) the patients that will develop the disease. Genetic factors play an important role in these diseases. A major goal is to identify genetic variants and their combination that can influence disease evolution. To that aim, knowledge models of biological processes at play appear essential. First, such knowledge models could be used to inform the analysis of genetic variants (identified through sequencing and microarray technologies), for instance by constraining statistical learning approaches. These models are also essential for the biological interpretation of the discovered variants.
    The objective of this post-doctoral project is to design approaches to integrate knowledge models of biological processes in neurodegenerative diseases in the analysis of genetic variants. These will include both healthy and pathological metabolic and signaling pathway models. Pathways models can formalize the relationships between different gene activations in a given biological process or cellular cycle. The building of such models and their use with patient-specific data relies on approaches from the domains of ontologies, semantic web and graph-based representations. Different knowledge bases, such as that of the Gene Ontology (www.geneontology.org) for describing gene products, Reactome (www.reactome.org) for describing pathways, or OMIM and the Disease Ontology for describing pathologies have been developed by the scientific community. However, many of these models are either relatively generic or developed for other types of diseases (mainly cancer). Specific models of neurodegenerative disease have been proposed but the tools to automatically use these models for analysis of genetic data are still underdeveloped. Furthermore, knowledge about regional effects (such as effect on specific brain structures) needs to be added for better integration with imaging data. The present project will thus aim to propose knowledge models which are better adapted to these pathologies. These knowledge models will be based upon the increasing interoperability between specialized data repositories enabled by the Linked Open Data Initiative. Another important element is the ability to create a mapping between the knowledge model and the genetic data to be analyzed (such as for instance sets of Single Nucleotide Polymorphisms or structural variants). Such a mapping is non-trivial, in particular in non-coding regions and because of distant regulations. The second aim of the project will thus be to develop mapping strategies that can map knowledge models to genetic data. To address both issues, we propose to use query building tools such as the Askomics (https://github.com/askomics/askomics) tool in development by Dyliss. Askomics supports both the integration of tabulated data into an RDF triplestore, and an intuitive interface for generating SPARQL queries in order to analyze them in combination with domain ontologies. Based on this approach, the first step of the project will be to integrate and standardize all genomic data produced in the project, and to link these datasets with external disease and pathway databases. The next step will be to extract for the local RDF database suitable gene-dependencies networks that will be used as a-priori knowledge for statistical methods. As a final step, the post-doc will represent the mapping between variants and regulated genes by taking into account additional genomic information.

    YOUR PROFILE
    • PhD in Computer Science, Bioinformatics, Computational Biology or a related field
    • Previous work on ontologies or semantic web technologies for genomic data would be a plus. Alternatively, an expertise in genomic sequence analysis (SNP, variants) would be highly appreciated.
    • Strong relational skills to interact with professionals from various backgrounds.
    • Ability to synthesize informations from different sources.
    • Excellent written and oral communication skills.

    Starting date: Around November 2017
    Duration: 18 months

    CONTACTS
    Olivier Colliot - [email protected]
    Ivan Moszer – [email protected]

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    Yesterday, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:10 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
39 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Working...